Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.3300 (1.52%) ($5.3300 - $5.3300) on Thu. Jan. 21, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.87% (three month average) | RSI | 72 | Latest Price | $5.3300(1.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 3.8% a day on average for past five trading days. | Weekly Trend | CAPR advances 18.9% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) JNK(29%) ARKG(19%) FXI(16%) ARKK(14%) TIP(13%) | Factors Impacting CAPR price | CAPR will decline at least -2.435% in a week (0% probabilities). URA(-32%) UNG(-23%) SLV(-22%) SIL(-20%) JETS(-18%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.435% (StdDev 4.87%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.16(3.29%) | 10 Day Moving Average | $4.81(10.81%) | 20 Day Moving Average | $4.31(23.67%) | To recent high | -1.7% | To recent low | 1.5% | Market Cap | $105m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |